Prestige Consumer Healthcare, Inc. (PBH)
49.92
+0.72
(+1.46%)
USD |
NYSE |
Oct 16, 16:00
49.94
+0.02
(+0.04%)
After-Hours: 20:00
Prestige Consumer Healthcare Free Cash Flow (Quarterly) : 67.08M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.08M |
| March 31, 2026 | 37.63M |
| December 31, 2025 | 75.26M |
| September 30, 2025 | 55.38M |
| June 30, 2025 | 78.18M |
| March 31, 2025 | 58.37M |
| December 31, 2024 | 63.52M |
| September 30, 2024 | 67.77M |
| June 30, 2024 | 53.62M |
| March 31, 2024 | 63.76M |
| December 31, 2023 | 69.48M |
| September 30, 2023 | 59.53M |
| June 30, 2023 | 46.61M |
| March 31, 2023 | 56.43M |
| December 31, 2022 | 53.14M |
| September 30, 2022 | 55.16M |
| June 30, 2022 | 57.20M |
| March 31, 2022 | 59.96M |
| December 31, 2021 | 64.07M |
| September 30, 2021 | 58.44M |
| June 30, 2021 | 67.80M |
| March 31, 2021 | 54.19M |
| December 31, 2020 | 43.50M |
| September 30, 2020 | 43.07M |
| June 30, 2020 | 72.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 47.86M |
| December 31, 2019 | 54.76M |
| September 30, 2019 | 46.36M |
| June 30, 2019 | 50.82M |
| March 31, 2019 | 47.51M |
| December 31, 2018 | 41.26M |
| September 30, 2018 | 36.65M |
| June 30, 2018 | 53.38M |
| March 31, 2018 | 51.56M |
| December 31, 2017 | 42.26M |
| September 30, 2017 | 52.19M |
| June 30, 2017 | 51.57M |
| March 31, 2017 | 6.382M |
| December 31, 2016 | 39.54M |
| September 30, 2016 | 49.03M |
| June 30, 2016 | 49.85M |
| March 31, 2016 | 36.87M |
| December 31, 2015 | 45.00M |
| September 30, 2015 | 46.17M |
| June 30, 2015 | 42.74M |
| March 31, 2015 | 49.71M |
| December 31, 2014 | 44.76M |
| September 30, 2014 | 26.50M |
| June 30, 2014 | 29.18M |
| March 31, 2014 | 30.62M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -5.378M |
| Phibro Animal Health Corp. | 5.225M |
| Structure Therapeutics, Inc. | -120.34M |
| ANI Pharmaceuticals, Inc. | 53.62M |
| Corcept Therapeutics, Inc. | 31.02M |